Skip to main content
. Author manuscript; available in PMC: 2018 Apr 27.
Published in final edited form as: Toxicol Appl Pharmacol. 2014 Dec 27;283(1):35–41. doi: 10.1016/j.taap.2014.12.006

Figure 4.

Figure 4

Coefficient of variation of the distribution of mean number-weighted alveolar volumes vs. age (months) in all treatment groups for both 6 month exposure and 36 month exposure and recovery cohorts. There was a significant increase in the CVn alv in the HDMA and HDMA + O3 groups compared to the FA group in the 36 month exposure and recovery cohort. *Significant difference (P<0.05) from the FA control lobe.